Company 4 Sc AG Deutsche Boerse AG
Equities
DE0005753818
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Business Summary
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Development of Small-Molecule Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -30.28% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
88.8
%
| 0 | 68.8 % | 0 | 88.8 % | -10.00% |
Germany
11.2
%
| 0 | 31.2 % | 0 | 11.2 % | -75.00% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,114,009 | 2,698,840 ( 26.68 %) | 0 | 26.68 % |
Company contact information
![address 4 Sc AG](https://cdn.zonebourse.com/static/address/469061.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+17.03% | 26.02B | |
-23.86% | 19.39B | |
-19.14% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- VSC Stock
- Stock
- Company 4 Sc AG